Russian TB Vaccine Enters Phase III Trials
- Published:
- First detected:
Insights by Echo AI
The Gamaleya Research Institute's tuberculosis vaccine has entered Phase III clinical trials, according to its scientific director, Alexander Gintsburg. This phase involves thousands of patients and aims to confirm the vaccine's benefits on a large scale. Statistical data processing is currently underway.
Source coverage
Aggregated
4
records merged
X / Twitter
1
0 unique
Telegram
1
1 unique
RSS
2
2 unique
4 Sources
Вакцина, защищающая от заражения туберкулезом, проходит третью фазу ис...
Вакцина Центра им. Н. Ф. Гамалеи, защищающая от заражения туберкулезом...
غاماليا: لقاح السل الروسي الجديد يدخل المرحلة الثالثة من التجارب السري...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
